Tyra Biosciences, Inc. · NASDAQ:TYRA
Ra Capital Management, L.P. reported a 21.20% stake in Tyra Biosciences, Inc. (Schedule 13D/A)
Event Mar 4, 2026 · Filed Mar 6, 2026
Ra Capital Management, L.P. reported a 21.20% stake in Tyra Biosciences, Inc., 12,266,575 shares, with active intent on Mar 4, 2026. Filed Mar 6, 2026 (Schedule 13D/A).
- Stake
- 21.20%
- Shares
- 12,266,575
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 21.20% | 12,266,575 |
| Peter Kolchinsky | 21.20% | 12,266,575 |
| Rajeev Shah | 21.20% | 12,266,575 |
| RA Capital Healthcare Fund, L.P. | 17.70% | 10,259,291 |
Source
Related
- Tyra Biosciences, Inc.
- Ra Capital Management, L.P.
- Tyra Biosciences, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 6, 2025
- Schedule 13D/A · Ra Capital Management, L.P. · Mar 31, 2025
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026